Metabolic syndrome and Alzheimer's disease: Mechanistic links and precision prevention (Review)
International Journal of Molecular Medicine · 12.11.2026 · 59 (1) · 1-16
DOI: 10.3892/ijmm.2026.6051 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 12.11.2026. Verfasst von Hanlu Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China. Hauptthemen laut MEDLINE: Alzheimer Disease, Metabolic Syndrome, Precision Medicine. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Metabolic syndrome (MetS) is associated with increased risk of Alzheimer's disease (AD), however, the majority of previous studies regard MetS as an isolated risk factor and focus on single pathways, lacking systematic understanding of combined effects among multiple metabolic components. The present review systematically summarizes the multifaceted mechanisms by which MetS promotes AD pathology, including insulin resistance and cerebral energy dysregulation, oxidative stress and mitochondrial dysfunction, neuroinflammation and glial cell activation, vascular dysfunction and dysregulation of the renin‑angiotensin system, as well as the central convergent signaling pathway involving glycogen synthase kinase‑3β. The present review further highlights emerging regulatory mechanisms involving the gut‑brain axis, epigenetic reprogramming, sex differences and hormonal effects and senescent microenvironment. By emphasizing the peripheral‑central crosstalk and interactive amplification of MetS components, the present review aimed to position AD as a central manifestation of systemic metabolic disorders in the brain and propose a multi‑domain precision strategy integrating lifestyle intervention, metabolic drug repurposing, gut microbiota regulation, anti‑aging therapy and biomarker‑guided subtype classification for intervention against MetS‑associated AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China.
- The First School of Clinical Medicine, Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China.
- College of Medical Technology, Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China.
- Department of Laboratory Medicine, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, Guizhou 550000, P.R. China.
Zitieren
APA
Chen, H., Ding, T., Zhu, Y., Yang, M., Wang, F., Chen, P., Lin, H., Kang, H., Hu, M., Zhou, J., & Wang, X. (2026). Metabolic syndrome and Alzheimer's disease: Mechanistic links and precision prevention (Review). International Journal of Molecular Medicine, 59(1), 1-16. https://doi.org/10.3892/ijmm.2026.6051
Vancouver
Chen H, Ding T, Zhu Y, Yang M, Wang F, Chen P, et al. Metabolic syndrome and Alzheimer's disease: Mechanistic links and precision prevention (Review). International Journal of Molecular Medicine. 2026;59(1):1-16. doi:10.3892/ijmm.2026.6051
BibTeX
@article{Chen2026,
author = {Chen, Hanlu and Ding, Tao and Zhu, Yifan and Yang, Mei and Wang, Fangsheng and Chen, Puwen and Lin, Haihong and Kang, Huapei and Hu, Maohong and Zhou, Jun and Wang, Xiaoling},
title = {Metabolic syndrome and Alzheimer's disease: Mechanistic links and precision prevention (Review)},
journal = {International Journal of Molecular Medicine},
year = {2026},
volume = {59},
number = {1},
pages = {1--16},
doi = {10.3892/ijmm.2026.6051}
}
EUVIMED